Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 65 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 43. Clear
Clear
Q2
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View → Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q2
INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark
View → Q1
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code
View → Q1
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q1
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q1
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $450,000.00 income
Copyright/Patent/Trademark, Health Issues
View → Q1
AMGEN, INC. for AMGEN INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View → Q1
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Copyright/Patent/Trademark
View → Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View → Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q1
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View → Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View → Q1
APOTEX CORP. for APOTEX CORP.
1st Quarter (Jan 1 - Mar 31) 2026 · Florida · House · Senate
Manufacturing, Trade (domestic/foreign), Copyright/Patent/Trademark
View → Q1
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View → 3A
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → 2A
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View → Q4
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code
View → Q4
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View → Q4
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View → Q4
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View → Q4
NOVARTIS for NOVARTIS
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues
View → Q4
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View → Q4
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · $170,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Page 1 of 3 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem